Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA

NCT00126685 is registered in ClinicalTrials.gov with Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen as lead sponsor.

NCT NCT00126685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA
Lead sponsor
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2005
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)